Mechanisms involved in normal and pathological osteoclastogenesis
- 18 April 2018
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 75 (14) , 2519-2528
Abstract
Osteoclasts are bone-resorbing cells that play an essential role in bone remodeling. Defects in osteoclasts result in unbalanced bone remodeling and are linked to many bone diseases including osteoporosis, rheumatoid arthritis, primary bone cancer, and skeletal metastases. Receptor activator of NF-kappaB ligand (RANKL) is a classical inducer of osteoclast formation. In the presence of macrophage-colony-stimulating factor, RANKL and co-stimulatory signals synergistically regulate osteoclastogenesis. However, recent discoveries of alternative pathways for RANKL-independent osteoclastogenesis have led to a reassessment of the traditional mechanisms that regulate osteoclast formation. In this review, we provide an overview of signaling pathways and other regulatory elements governing osteoclastogenesis. We also identify how osteoclastogenesis is altered in pathological conditions and discuss therapeutic targets in osteoclasts for the treatment of skeletal diseases.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR069562, AR073156)
This publication has 84 references indexed in Scilit:
- Feedback inhibition of osteoclastogenesis during inflammation by IL‐10, M‐CSF receptor shedding, and induction of IRF8Annals of the New York Academy of Sciences, 2011
- Cancer to bone: a fatal attractionNature Reviews Cancer, 2011
- PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone LossCell Metabolism, 2010
- DAP12 Couples c-Fms Activation to the Osteoclast Cytoskeleton by Recruitment of SykMolecular Cell, 2008
- Chloride channels as drug targetsNature Reviews Drug Discovery, 2008
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2Journal of Clinical Investigation, 2006
- Regulation of osteoclast function and bone mass by RAGEJournal of Experimental Medicine, 2006
- Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-κB transactivation by RANKLCell Death & Differentiation, 2006
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002